The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
07:00 06-Oct-2017 BXP Signs a Non-Binding MoU with Nuvista Pharma RNS +9.50% Up
07:00 02-Oct-2017 BXP Change of Broker RNS -1.00% Down
07:00 18-Sep-2017 BXP Commences Export to Canada RNS +1.97% Up
07:00 25-Jul-2017 BXP FDA approves Beximco Pharma Methocarbamol tablets RNS +0.53% Up
07:00 28-Apr-2017 BXP Financial Results for the Third Quarter of 2016-17 RNS +1.54% Up
07:00 27-Jan-2017 BXP Half year results 2016-17 RNS +11.36% Up
07:00 25-Jan-2017 BXP Beximco Pharma forms JV with BioCare Manufacturing RNS +11.82% Up
07:00 19-Dec-2016 BXP US FDA approves Metformin for diabetes control RNS +4.06% Up
10:12 16-Dec-2016 BXP Payment of Cash Dividend RNS +2.61% Up
13:54 12-Dec-2016 BXP Stock Dividend Issued and Total Voting Rights RNS -2.76% Down
07:00 21-Nov-2016 BXP AGM Statement RNS +6.78% Up
07:00 15-Nov-2016 BXP 1st Quarter Results RNS +12.15% Up
07:00 25-Oct-2016 BXP Receives second product approval from the US FDA RNS +17.85% Up
07:00 20-Oct-2016 BXP Results for the 18 month period ended 30 June 2016 RNS +18.75% Up

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 17 Dhanmondi R/A, Road No. 2, Dhaka, 1205, Bangladesh
Company website http://www.beximco-phar...
Market cap(in millions)* £ 261.58
Listing/Admission to trading 21 Oct 2005
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index -
FTSE sector -
FTSE sub-sector -
Country of share register US
Segment AIMI
MiFID Status MTF
Exchange market size 5,000
ISIN number US0885792061

BEXIMCO PHARMA share news analysis (BXP)